GABRIEL
ZUBILLAGA GARMENDIA
Investigador/a en el periodo 1990-2016
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario Virgen del Rocío (6)
2017
-
Effectiveness of a simple intervention on management of acute exacerbations of chronic obstructive pulmonary disease and its cardiovascular comorbidities: COREPOC study
Medicina Clinica, Vol. 149, Núm. 6, pp. 240-247
2016
-
Factors associated with fatality during the intensive phase of anti-tuberculosis treatment
PLoS ONE, Vol. 11, Núm. 8
-
Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment
Archivos de Bronconeumologia, Vol. 52, Núm. 5, pp. 262-268
2007
-
Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME
Archivos de Bronconeumologia, Vol. 43, Núm. 2, pp. 64-72
2006
-
Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 3, pp. 536-545
2003
-
Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults
Journal of Antimicrobial Chemotherapy, Vol. 52, Núm. 5, pp. 826-836